← FDA Drug Approvals (Drugs@FDA)

LAMIVUDINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: APOTEX · Approved 2014-01-02

Drug application

FDA Application #
ANDA202941
Application type
Abbreviated New Drug Application (Generic)
Brand name
LAMIVUDINE
Generic name
LAMIVUDINE
Active ingredients
LAMIVUDINE
Dosage form
TABLET
Route
ORAL
Marketing status
Prescription
Sponsor
APOTEX
Manufacturer
Apotex Corp.
First approval
2014-01-02

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown